Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives
- PMID: 28287385
- PMCID: PMC5649956
- DOI: 10.2450/2017.0301-16
Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives
Conflict of interest statement
The Authors declare no conflicts of interest.
Comment on
-
Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.Blood Transfus. 2017 Oct;15(6):562-567. doi: 10.2450/2017.0199-16. Epub 2017 Mar 7. Blood Transfus. 2017. PMID: 28287382 Free PMC article.
References
-
- Guyatt GH, Akl EA, Crowther M, et al. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141( 2 Suppl):7S–47S. - PMC - PubMed
-
- Lippi G, Franchini M, Favaloro EJ. Pharmacogenetics of vitamin K antagonists: useful or hype? Clin Chem Lab Med. 2009;47:503–15. - PubMed
-
- Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants - the present and the future. Pathology. 2011;43:682–92. - PubMed
-
- Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus? Clin Chem Lab Med. 2015;53:185–97. - PubMed
-
- Favaloro EJ, Lippi G. Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost. 2015;41:208–27. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical